MIRA

COM:MIRAPHARMACEUTICALS

MIRA Pharmaceuticals

  • Stock

USD

Last Close

1.26

22/11 21:00

Market Cap

8.27M

Beta: -

Volume Today

359.54K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
Sep '24
net income
-56.98K
-
-1.48M
2,488.94%
-2.42M
64.26%
-1.81M
25.27%
-1.35M
25.47%
-1.34M
0.63%
-1.27M
5.59%
-3.59M
183.37%
-5.79M
61.31%
-1.72M
70.32%
-1.69M
1.54%
-2.04M
20.84%
depreciation and amortization
deferred income tax
stock based compensation
1.00M
-
147.80K
85.23%
147.80K
0%
147.80K
0%
737.20K
398.78%
1.45M
96.98%
500.21K
-
269.01K
-
change in working capital
35.63K
-
-571.37K
1,703.58%
147.89K
125.88%
345.59K
133.69%
224.48K
35.04%
116.28K
48.20%
-427.79K
467.88%
-39.83K
90.69%
-288.36K
624.04%
168.03K
158.27%
222.59K
32.48%
-390.62K
275.49%
accounts receivables
11.86K
-
-11.86K
-
inventory
accounts payables
-241.01K
-
97.70K
140.54%
145.88K
49.32%
-89.31K
161.22%
other working capital
35.63K
-
345.59K
-
116.28K
-
-427.79K
467.88%
-39.83K
90.69%
-47.35K
18.88%
58.47K
223.48%
76.71K
31.21%
-289.45K
477.31%
other non cash items
4.92K
-
3.86K
21.54%
2.32K
40.02%
2.31K
0.39%
1.77K
23.45%
1.65K
6.40%
295.89K
17,800%
414.24K
40.00%
3.94M
851.30%
390.65K
90.09%
458.92K
17.48%
323.36K
29.54%
net cash provided by operating activities
-16.42K
-
-2.04M
12,337.16%
-1.27M
37.74%
-1.31M
3.40%
-975.44K
25.82%
-1.08M
10.24%
-660.81K
38.55%
-1.76M
166.53%
-2.14M
21.23%
-1.05M
50.84%
-863.93K
17.68%
-1.84M
113.22%
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
debt repayment
-40K
-
-86.48K
-
-219.54K
153.86%
-2.24M
-
common stock issued
1.58M
-
135K
91.48%
900K
566.67%
285K
68.33%
-46.26K
116.23%
-163.68K
253.83%
9.05M
5,631.62%
-1.35M
114.91%
3.13M
-
common stock repurchased
dividends paid
other financing activites
-23.11K
-
-228.24K
887.69%
-160K
29.90%
-223.58K
39.74%
854.00K
481.97%
858.42K
0.52%
1.07M
24.36%
-1.45M
235.79%
-19.15K
98.68%
-24.34K
27.06%
159.01K
753.44%
3.16M
1,889.05%
net cash used provided by financing activities
16.89K
-
1.36M
7,926.07%
-25K
101.84%
676.42K
2,805.69%
1.14M
68.39%
725.68K
36.29%
684.29K
5.70%
7.60M
1,011.34%
869.35K
88.57%
-24.34K
102.80%
159.01K
753.44%
3.16M
1,889.05%
effect of forex changes on cash
net change in cash
469
-
-686.79K
146,537.31%
-1.30M
88.82%
-638.57K
50.76%
163.56K
125.61%
-349.63K
313.76%
23.47K
106.71%
5.84M
24,793.53%
-1.27M
121.66%
-1.07M
15.16%
-704.91K
34.36%
1.32M
287.37%
cash at beginning of period
-465.04
-
2.81M
604,252.76%
2.12M
24.44%
825.98K
61.09%
187.41K
77.31%
350.98K
87.27%
1.35K
99.62%
24.82K
1,740.10%
5.87M
23,540.70%
4.60M
21.57%
3.53M
23.33%
2.82M
19.98%
cash at end of period
3.96
-
2.12M
53,604,975.76%
825.98K
61.09%
187.41K
77.31%
350.98K
87.27%
1.35K
99.62%
24.82K
1,740.10%
5.87M
23,540.70%
4.60M
21.57%
3.53M
23.33%
2.82M
19.98%
4.14M
46.77%
operating cash flow
-16.42K
-
-2.04M
12,337.16%
-1.27M
37.74%
-1.31M
3.40%
-975.44K
25.82%
-1.08M
10.24%
-660.81K
38.55%
-1.76M
166.53%
-2.14M
21.23%
-1.05M
50.84%
-863.93K
17.68%
-1.84M
113.22%
capital expenditure
free cash flow
-16.42K
-
-2.04M
12,337.16%
-1.27M
37.74%
-1.31M
3.40%
-975.44K
25.82%
-1.08M
10.24%
-660.81K
38.55%
-1.76M
166.53%
-2.14M
21.23%
-1.05M
50.84%
-863.93K
17.68%
-1.84M
113.22%

All numbers in USD (except ratios and percentages)